Trial Profile
A study to evaluate the efficacy and safety of rosuvastatin in the long-term treatment of hypercholesterolaemic subjects with coronary heart disease as measured by intravascular ultrasonography.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Coronary disorders; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms COSMOS
- Sponsors AstraZeneca
- 30 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Dec 2007 Status changed from recruiting to in progress.
- 04 Apr 2007 The expected completion date for this trial is now 1 Oct 2008.